Asahi Kasei ends the 2nd phase of its $2.2 billion buyout of Zoll Medical, leaving it with more than 93% of the automated external defibrillator maker.

The FDA clears OrthoSensor's Verasense device, designed to help surgeons fit knee replacement...
ArtVentive Medical Group wins CE Mark approval in the European Union for its EOS peripheral vascular...
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...
Experts fear the online health insurance marketplace will be burdened with tech problems and...